Dr Jack Cush reviews the news and journal articles from this past week on RheumNow.com
Global Burden of Disease study published in Arthritis & Rheumatology, shows that in 2017 there were 1.3 billion cases of musculoskeletal disorders worldwide, leading to 121,300 deaths and 138.7 million disability adjusted life years https://bit.ly/3mmKtbH
Dr. John Cush RheumNow
5 years 9 months ago
How FAST can you go? with Dr. Michael Pillinger #acr20
https://t.co/YV2lyAAEyY https://t.co/bycb4KHf9S
Following the FDA issuance of an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for the prevention of COVID-19 in persons aged ≥16 years.
Dr. John Cush RheumNow
5 years 9 months ago
Benlysta First Agent Approved for Lupus Nephritis: GlaxoSmithKline announced yesterday that the FDA has approved belimumab (Benlysta) for use in adults with active lupus nephritis (LN) receiving background/standard therapy.
https://t.co/O7CBAn55t2 https://t.co/RWNDzUqxhM
The results of the National Residents Matching Program (NRMP) match in rheumatology are out and show that rheumatology fellowship was both competitive and highly sought after.
Dr. John Cush RheumNow
5 years 9 months ago
Herpes Zoster on the Brain and Vaccinations with Dr Kevin Winthrop #ACR20
https://t.co/XdQO1ztD1I
ACR_Journals ACR_Journals
5 years 9 months ago
Early view in ACR Open Access:
Patient Perspectives on Gout and Gout Treatments: A Patient Panel Discussion That Informed the 2020 American College of Rheumatology Treatment Guideline
https://t.co/QY6pofhamT
Dr. John Cush RheumNow
5 years 9 months ago
Filgotinib Bows Out of the RA Race in the USA--Gilead Sciences Inc announced yesterday that it has decided not to pursue the rheumatoid arthritis (RA) indicatin for its once daily oral JAK inhibitor, filgotinib (also named Jyseleca).
https://t.co/XAR3T8AQpR https://t.co/GlQB9L8Jnd
Dr. John Cush RheumNow
5 years 9 months ago
Checkout Dr. Kevin Winthrops RheumNow interview for insights and caveats on the use of COVID-19 vaccination in patients with rheumatic disease and those taking biologics or DMARDs. To hold MTX or not? https://t.co/C1fgCcKgWZ
Dr. John Cush RheumNow
5 years 9 months ago
Everyone (Docs and patients) should watch this great video by Dr. Aggarwal from UPitt -he reviews the COVID-19 vaccines, differences, risks and compares to other vaccines https://t.co/j9iqxdgXnL
Ethan Craig rheumecraig
5 years 9 months ago
Pretty friggin amazing. 13 months since first case in China. And now getting a vaccine. Thank god for people that are far smarter than me. I am awed by this feat. https://t.co/PZ3oQTOw2l
Christina Downey, MD, RhMSUS, DipABLM cdowneymd
5 years 9 months ago
Leading by example at @LLUHPhysicians @LLU_Rheum! We’re all in this together, get vaccinated as soon as you’re able. #COVID #pandemic https://t.co/edPsVUD0nf
Dr. John Cush RheumNow
5 years 9 months ago
This is the beginning of the END. Please get your COVID vaccine! How cool that the nurse with the needle is my RA patient https://t.co/Hk6ZVCf3WS
Dr. John Cush RheumNow
5 years 9 months ago
Axial Spondyloarthritis - Diagnosis, Imaging and Treatments: Dr. Lianne Gensler
#ACR20
https://t.co/PGTiP7y5L8 https://t.co/nQEW6dlwUt
The exponential rise in deaths from the coronavirus (COVID-19) in the last several months is put into perspective by JAMA Viewpoint article noting that current US death rates of > 3000 per day from COVID-19 is greater than that seen in one day on September 11, 2001 (9/11 attacks, claimed 2988 lives) or by a fictional catastrophe of 15 Airbus 320 jetliners (150 passengers each) crashing daily.
